The global electrophoresis market is poised for significant expansion, with market value anticipated to grow from USD 2,268.8 million in 2023 to a projected USD 3,523.5 million by 2033. This robust growth trajectory, underpinned by a Compound Annual Growth Rate (CAGR) of 4.5%, is driven by increased demand for advanced laboratory instruments, primarily capillary electrophoresis systems.
As forensic laboratories and research facilities worldwide prioritize precision and efficiency, capillary electrophoresis instruments are transforming laboratory workflows. These innovative systems streamline processes, allowing operators to input new work while concurrently analyzing samples, resulting in enhanced productivity and throughput. Additionally, advancements in the speed, precision, and sensitivity of electrophoresis equipment are broadening its applications and accelerating global demand.
The demand for electrophoresis systems is further fueled by rising healthcare needs and the global surge in chronic diseases, which are spurring the development of innovative drugs and therapies. Increased interest in gene, DNA, and protein research also underscores the market’s growing relevance, positioning it as a vital tool in modern molecular and clinical laboratories.
Emerging economies are expected to play a pivotal role in driving the electrophoresis market’s growth, with rapid advancements in research infrastructure and a thriving startup ecosystem bolstered by capital investments. This trend is expected to propel further innovation, creating new opportunities for advanced technology solutions within the market.
Key players in the electrophoresis market are focusing on strategies to optimize the cost of ownership, making the technology more accessible. By reducing sample processing costs and consumable expenses, these companies aim to increase adoption among end-users across various sectors. Many industry leaders are also pursuing mergers, acquisitions, and partnerships to expand their product portfolios and capitalize on the rising demand.
“With the rapid increase in patients affected by lifestyle and chronic diseases, healthcare systems are facing unprecedented pressures,” stated an analyst at FMI. “Governments are responding by investing in medical research and cutting-edge technology to strengthen healthcare infrastructure. To meet these demands, key electrophoresis players are focusing on cost reduction strategies, aiming to boost the affordability and accessibility of these instruments and drive accelerated sales.”
As healthcare challenges evolve, the electrophoresis market stands ready to play a crucial role in the advancement of diagnostics, drug development, and genetic research. With sustained investment and innovation, the market is set to make a lasting impact on healthcare and scientific research over the coming decade.
Key Takeaways from the Electrophoresis Market Report:
- The United States is the leading market for electrophoresis, regionally as well as globally. The country is predicted to acquire a market share of 28.6% in 2023.
- Within Europe, Germany is the top contender with a market share of 7% in 2023.
- In Asia Pacific, India is estimated to account for a significant CAGR of 5.9% through 2033.
- Australia is a budding market for electrophoresis. The country is predicted to register a CAGR of 3.8% through 2033.
- Pharma and biotech companies are projected to acquire a share of 27% of overall electrophoresis market in 2023.
- The reagents and consumables segment is forecast to obtain value share of 48.67% in 2023.
Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!
Key Developments Taking Place in the Electrophoresis Market:
- In October 2022, CMP Scientific Corp. announced that it has inked a co-marketing contract with Agilent Technologies to offer an integrated CE-MS solution to the pharmaceutical and life science industry. The agreement is aimed at the advancement of capillary electrophoresis to offer mass spectrometry solutions.
- In March 2022, Thermo Fisher Scientific launched SeqStudio Flex Series Genetic Analyzer to facilitate cutting-edge research in areas like infectious disease and gene editing. Capillary Electrophoresis (CE), which assists fragment analysis and Sanger sequencing is a critical tool to improve clinical research. The SeqStudio Flex Genetic Analyzer offers superior-quality CE technology with data precision and dependable performance.
- In June 2021, Thermo Fisher Scientific revealed that it has signed a contract with Advanced Electrophoresis Solutions Ltd to boost therapeutic development with the help of cutting-edge protein analysis.
Key Players:
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Helena Laboratories Corporation
- Hoefer, Inc. (Harvard Biosciences)
- Merck KGaA
- PerkinElmer Inc.
- SCIEX
- SERVA Electrophoresis GmbH
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Shimadzu Corporation
- Takara Bio, Inc.
- TBG Diagnostic Ltd
- Cleaver Scientific
- QIAGEN N.V.
- Eurogentec
- Sebia Group
- Analytik Jena
- Lonza Group
Key Market Segments Covered in Electrophoresis Market Research:
By Product:
- Instruments
- Horizontal Systems
- Vertical Systems
- Capillary Electrophoresis Systems
- Automatic Electrophoresis Systems
- Reagents and Consumables
- Gel
- Polyacrylamide Gel Electrophoresis
- Agarose Gel Electrophoresis
- Others
- Buffers & Others
- Gel
- Software
By End-use Industry:
- Hospitals
- Diagnostic Laboratories
- Pharma & Biotech Companies
- CROs and CMOs
- Academic & Research Institutes
- Forensic Laboratories
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube